Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Tumor-based case-control studies of infection and cancer: muddling the when and where of molecular epidemiology.

Engels EA, Wacholder S, Katki HA, Chaturvedi AK.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1959-64. doi: 10.1158/1055-9965.EPI-14-0282. Epub 2014 Jul 25.

2.

Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.

Colditz GA.

Crit Rev Food Sci Nutr. 2010;50 Suppl 1:10-2. doi: 10.1080/10408398.2010.526838.

3.

Cancers in Australia in 2010 attributable to infectious agents.

Antonsson A, Wilson LF, Kendall BJ, Bain CJ, Whiteman DC, Neale RE.

Aust N Z J Public Health. 2015 Oct;39(5):446-51. doi: 10.1111/1753-6405.12445.

4.

On the etiology of anal squamous carcinoma.

Frisch M.

Dan Med Bull. 2002 Aug;49(3):194-209. Review.

PMID:
12238281
5.

Infections and cancer: established associations and new hypotheses.

de Martel C, Franceschi S.

Crit Rev Oncol Hematol. 2009 Jun;70(3):183-94. doi: 10.1016/j.critrevonc.2008.07.021. Epub 2008 Sep 20. Review.

PMID:
18805702
6.

Febrile infectious childhood diseases in the history of cancer patients and matched controls.

Albonico HU, Bräker HU, Hüsler J.

Med Hypotheses. 1998 Oct;51(4):315-20.

PMID:
9824838
7.

Looking backwards from outcome to exposure to assess cancer latency.

Smith AH.

J Chronic Dis. 1987;40 Suppl 2:113S-117S.

PMID:
3667857
8.

Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.

Platz EA, De Marzo AM, Giovannucci E.

J Cell Biochem. 2004 Feb 15;91(3):553-71. Review.

PMID:
14755685
9.
10.
11.

Role of infectious diseases in human carcinogenesis.

Herrera LA, Benítez-Bribiesca L, Mohar A, Ostrosky-Wegman P.

Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):284-303. Review.

PMID:
15744742
12.

The cancer burden attributable to biologic agents.

Schottenfeld D, Beebe-Dimmer J.

Ann Epidemiol. 2015 Mar;25(3):183-7. doi: 10.1016/j.annepidem.2014.11.016. Epub 2014 Nov 20. Review.

PMID:
25523895
13.
14.

Risk of lymphatic or haematopoietic cancer mortality with occupational exposure to animals or the public.

Svec MA, Ward MH, Dosemeci M, Checkoway H, De Roos AJ.

Occup Environ Med. 2005 Oct;62(10):726-35.

15.

Surveillance for waterborne-disease outbreaks--United States, 1999-2000.

Lee SH, Levy DA, Craun GF, Beach MJ, Calderon RL.

MMWR Surveill Summ. 2002 Nov 22;51(8):1-47.

16.

Case-case comparisons to study causation of common infectious diseases.

McCarthy N, Giesecke J.

Int J Epidemiol. 1999 Aug;28(4):764-8. Review.

PMID:
10480708
17.

Case-control and two-gate designs in diagnostic accuracy studies.

Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM.

Clin Chem. 2005 Aug;51(8):1335-41. Epub 2005 Jun 16. Review.

18.

Population attributable fraction of infection-related cancers in Korea.

Shin A, Park S, Shin HR, Park EH, Park SK, Oh JK, Lim MK, Choi BY, Boniol M, Boffetta P.

Ann Oncol. 2011 Jun;22(6):1435-42. doi: 10.1093/annonc/mdq592. Epub 2010 Oct 25.

PMID:
20974652
19.
20.

A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer.

Nurgalieva ZZ, Graham DY, Dahlstrom KR, Wei Q, Sturgis EM.

Head Neck. 2005 Jan;27(1):22-7.

PMID:
15459921

Supplemental Content

Support Center